Highmark Interactive Inc. signed a strategic partnership with Nsight Health Inc. As part of the agreement, Nsight will utilize Highmark?s FDA approved software to administer remote patient care for its patients while managing the entire administration process. Highmark?s EQ Balance has been cleared by the US FDA as Class 2 Software as a Medical Device (SaMD) is reimbursed by US Medicare/Medicaid and other third party insurance companies when utilized by patients to monitor and track balance. Nsight enables Highmark to focus on its core competency of software while leveraging Nsight?s best practices for billing, operations and execution.

The Company is expected to start integration and demo in August, while ramping up volumes shortly thereafter.